Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) EPS (Diluted) (2024 - 2026)

Updated

Evommune's EPS (Diluted) came in at -$0.89 for Q2 2026, compared with -$8.80 a year earlier.

Analysis

Evommune (EVMN) EPS (Diluted) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evommune reported EPS (Diluted) of -$2.62; for FY2025, it came in at -$11.22.

  • Going back by year, EPS (Diluted) was -$44.29 in FY2024.
  • The five-year range for quarterly EPS (Diluted) is -$13.74 (Q4 2024) to -$0.64 (Q1 2026).
  • Business Quant data shows EVMN's EPS (Diluted) at -$0.64 (Q1 2026), -$4.61 (Q4 2025) and -$8.07 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.22
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.04
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.00
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.08
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.94
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.56
10 Evommune 285.17 Mn -352.34 Mn - -0.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -0.64
Dec 31, 2025 -4.61
Sep 30, 2025 -8.07
Jun 30, 2025 -8.80
Mar 31, 2025 -9.48
Dec 31, 2024 -13.74
Sep 30, 2024 -10.47
API Access

Evommune EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=EVMN&period=max&api_key=YOUR_API_KEY